Osiris up after beating Street

Osiris Therapeutics Inc. (NASDAQ:OSIR) jumped $4.45 (33%) to $17.76 on Friday after reporting 3Q13 financial results that beat the Street. Product revenues in the quarter were $6.9 million, beating the Street's estimate of $6.7 million and up 220% from $2.2 million in 3Q12. The company had a 3Q13 diluted loss per share of $0.05, narrower than the Street's estimate of a loss per share of $0.10. The company reported a loss per share of $0.09 in 3Q12. ...